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1. Introduction 
Coronary artery bypass surgery is a procedure that started off with the first implantation of 
the internal mammary artery to the cardiac muscle in 1946 by Vineberg [Vineberg AM, 
1954]. Later, the coronary anastomosis distal to the occlusion using the saphenous vein graft 
(SVG) or the internal mammary artery (IMA) was experimentally conceived by Murray 
[Murray et al, 1954]. Bailey et al [Bailey et al, 1957] were the first group to approach the 
problem of coronary occlusion in 1957. Though the pioneers of OPCAB were Goetz and 
colleagues [Goetz et al, 1961] and Kolessov [Kolessov VL, 1967] who performed the 
procedure in isolated cases. The first clinical series of consecutive patients was by Trapp and 
Bisarya [Trapp WG, Bisarya R,1975] and Ankeney [Ankeney JL,1975]. 
Then, with the development of direct coronary surgery, under the leadership of Favaloro 
[Favaloro RG,1968] and Green and coworkers [Green GE, Stertzer SH 1968], with 
procedures being performed in an arrested heart with the use of extracorporeal circulation, 
off-pump coronary surgery was abandoned. Thus the surgeons all over the world started 
performing CABG on the heart lung machine , and that became the standard of care for 
patients with coronary artery disease. 
 In 1981 Enio Buffolo [Buffolo E ,et.al,1985]from Brazil and Benneti [Benetti FJ,1985] from 
Argentina had started experimenting on this technique of Direct Myocardial 
revascularization. Both of them published their series around 1985 which rekindled the idea 
of OPCAB in the western world. It was probably the idea of minimally invasive direct 
coronary artery bypass graft (MIDCABG), introduced in the mid-1990s by Benneti [Benetti 
FJ ,1985,1995], that called attention to the possibility and advantages of not using CPB. 
Calafiore's [Calafiore AM,et al,1996,1998] publications re- enforced the advantages of the 
LAST(left anterior small thoracotomy) operation. The LIMA stitch was acclaimed as an 
extraordinary step in the development of off-pump coronary surgery, which allowed 
grafting of posterior branches of the coronary arteries. The introduction of stabilizers in the 
mid 1990s further facilitated the procedure[Borst C,1996]. Eric Jansen, was one of those 
surgeon in the mid nineties who was probably the man who had made the word -Octopus- 
so very popular in the rest of the world. The article published in 1991 by Benetti [Benetti F.J 
et al,1991] in Chest, gave confidence to the Cardiac surgeons around the world to perform 
OPCAB in all anterior vessels. But even then the circumflex territory became a danger zone 
for most surgeons to perform a safe coronary anastomoses. Though LIMA stitch was used 
quite often, it was the availability of the Positioners that that made the process of 
Verticalisation of the heart more comfortable. 
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By the end of the 90's, most of the surgeons in India and in the far east had been performing 
OPCAB in 90% of their Coronary artery patients, but by early 2000, there was a sharp 
decline in the numbers, as most of the surgeons did not find the comfort zone in OPCAB 
surgery, and that their patency rates were being questioned. In the 1990s the visibility of 
coronary anastomosis was again a doubtful proposition, and also converting, and going on 
to the pump became a recipe for disaster. Then came the comparative trials of OPCAB and 
ONCAB , which obviously brought in results which showed that both the techniques 
produce nearly the same results, and that the patency was a question of concern[Kim KB,et 
al,2001&.Puskas JD.et al,2001] The Rooby trial showed that, at 1 year of follow-up, patients 
in the off-pump group had worse composite outcomes and poorer graft patency than did 
patients in the on-pump group[A. Laurie Shroyer,et al,NEJM,2009]. The surgeons had then 
come to a conclusion that OPCAB is good in experienced hands and the results in that group 
of people have been outstanding. 
The appeal of avoiding cardiopulmonary bypass with its direct and indirect physiological 
insult, the prospect of improved clinical outcomes, and the favorable economic impact gives 
OPCAB the potential of preference that may mark the dawn of a new era in our search for 
the optimal surgical strategy for the treatment of coronary artery disease. 
OPCAB has been performed in many different ways. It’s like different ways of skinning a 
cat. Ultimately, the gold standard of a perfect patent coronary anastomosis remains the 
corner stone of a good surgeon and a good operation. It is to be emphasized here that 
Coronary artery bypass surgery has a come a long way from performing them off pump, 
then on pump and now going back to off pump. But the most important point, one has to 
bear in mind is that , the surgeon has to do what he is most comfortable with and by which 
he would be able to give the best result. 
The topic of Re-engineering in OPCAB came up , because, there was an engineering that 
was done during the early phase of OPCAB by the great pioneers of this procedure. But 
what happened along the way was that these procedures were not reproducible by lesser 
mortals like us and hence we had to re-engineer this procedure to suit us. 
2. Theorotical reason of avoiding the pump 
It is logical to suppose that avoiding CPB would abolish the SIRS (systemic inflammatory 
response syndrome)and its untoward physiological impact. [Gu Y.J, 1999]. Gu Y.J, 
investigated the inflammatory response with OPCAB, and found that complement 
activation and consequently systemic inflammatory response occurred (due to surgical 
trauma) but the extent and severity were curtailed.  
Comparison with on-pump CABG confirms a limited and less severe form of inflammatory 
response. Strüber [Strüber M.,et al,1999&, Matata B.M.et al,2000] and Matata  and their 
coworkers reported significant increases in the levels of specific biological markers of 
inflammation following on-pump CABG compared to OPCAB. The inflammatory indicators 
that were evaluated in both studies and their results are summarized: 
 Activated complement factor 3a (C3a) demonstrated between 5- and 12-fold rise over 
the preoperative level after commencement of CPB, and minimal rise in the OPCAB 
patients.  
 Proinflammatory interleukin 8 (IL-8) increased 5-folds with CPB whilst the level was 
only slightly altered with OPCAB.  
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 Tumor necrosis factor (TNF-) peaked 24–48 h after CPB at a significantly higher value 
compared to OPCAB patients who had no increase. Tumor necrosis factor receptors 1 
and 2 were elevated to three times their preoperative level only with CPB.  
 Different markers tested in each study (interleukin 6 and plasma elastase) were 
significantly elevated with CPB. OPCAB patients showed a blunted response.  
The other variables of CPB such as haemodilution, non-pulsatile flow, and aortic cross-
clamping, which may act in concert with SIRS to increase postoperative morbidity, are 
eliminated by the avoidance of CPB. 
Thus avoiding the heart lung machine would be a logical solution in performing coronary 
artery bypass surgery 
3. Myocardial preservation 
Adequate myocardial preservation is crucial in CABG operations. Preoperative resuscitation 
of ischemic myocardium enables recruitment of hibernating myocardium and forms an 
important component of any myocardial protection strategy. The intraoperative strategy 
varies (within physiological boundaries) as much from patient to patient as it is from 
surgeon to surgeon, to the extent that a good clinical outcome becomes the ultimate 
determinant of the optimal strategy. Even with the same surgeon, the strategy is adapted to 
the patient and clinical scenario that a prescriptive regimen is not standard. The objective of 
intraoperative myocardial preservation is to enable efficient myocardial energy 
management by reducing cardiac metabolic demands on the one hand, while improving 
myocardial oxygen supply and utilization on the other [Buckberg G.D et.al,1996].  
In on-pump CABG, cardioplegia or cross-clamp fibrillation are conventional methods of 
intraoperative myocardial protection. Cardioplegia favorably affects myocardial energy 
metabolism but results in the alteration of both the intra- and extracellular milieu and, 
together with CPB can precipitate changes in cardiac performance postoperatively 
[Mehlhorn U.,1995]. Cross-clamp fibrillation can increase the endocardial viability ratio and 
lead to similar changes in cardiac function. In both strategies of myocardial protection, a 
period of global myocardial ischemia is followed by reperfusion with oxygen-rich blood 
predisposing to reperfusion injury which manifests as myocardial stunning and 
arrhythmias in the early postoperative period.  
Since deliberate induction of global ischemia is unnecessary in OPCAB, it is logical to 
suppose that iatrogenic biochemical injury to the myocardium would not occur. More so, 
the blunted inflammatory response with avoidance of CPB is characterised by low 
production of IL-8 which is involved in myocardial injury . In fact, Atkins et al. first 
suggested that OPCAB preserved cardiac function in 1984 [Atkins C.W .et al,1984]. In 
different prospective randomized studies, Ascione [Ascione R.et al,1999], Penttilä [Penttilä 
H.J.,et al,2001], Van Dijk [Van Dijk D..et al,2001], Czerny [Czerny M.,et al 2001], Bennetts 
[Bennetts J.S.et al,2002], and Masuda [Masuda M.et al,2002], and their collaborators reported 
minimal change in the biochemical markers of myocardial injury (troponin T and/or 
creatinine kinase-MB isoenzyme), and in some cases, better myocardial function after 
OPCAB compared to on-pump CABG. Changes in myocardial metabolism indicative of 
oxidative stress due to local ischemia when the target coronary artery is occluded to enable 
visualization for distal anastomoses have been reported in OPCAB [Matata B.M. et al 2002]. 
Compared to on-pump CABG, OPCAB is associated with better myocardial energy 
preservation,
 
less oxidative stress and minimal myocardial damage [Penttilä H.J et al.2001]. 
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However, emerging evidence suggests that intraoperative myocardial protection in OPCAB 
can provide an added advantage [.Guyton R.A. Et al,200 & Muraki S.et al.2001]. In their 
pioneering report, Trapp and Bisarya  gave an exquisite description of coronary perfusion 
and the instantaneous improvement in the ECG and blood pressure during OPCAB. 
Vassiliades et al. [Vassiliades T.A .et al,2002] compared active coronary perfusion using a 
perfusion pump, with passive perfusion by a cannula connected from the aorta
 
to the graft, 
and no coronary perfusion, after the distal anastomosis
 
in a randomized clinical trial. They 
found lower troponin I
 
levels with active and passive coronary perfusion, but cardiac
 
performance was better with active coronary perfusion. The use
 
of intracoronary shunt 
during OPCAB has also been shown to preclude
 
left ventricular dysfunction [Yeatman M.et 
al 2002].
 
 
Reperfusion injury can occur from regional ischemia due to a combination of underlying 
coronary obstructive pathology, stabilization and anastomotic techniques, compounded by 
episodes of hypotension which precede revascularisation. The precarious normoxic and 
normothermic passive coronary perfusion may be insufficient to protect against myocardial 
damage in such clinical scenarios.  
The concept of myocardial protection in OPCAB is less tedious. In most cases passive 
coronary perfusion with intracoronary shunts will suffice, but in the presence of heightened 
cardiac risk such as recent acute myocardial ischemia or infarction, and severely impaired 
left ventricular function active coronary perfusion is advantageous especially in multi-vessel 
revascularization.  
The role of Intra-aortic balloon pump  (IABP)in patients with Ischemic myocardium and in 
low ejection fraction would be discussed later in the chapter. As of today, apart from using 
intra coronary shunt, the use of aorto-coronnary shunts in some instances have been a 
disposable worth remembering. 
Hemodynamic instability has been the major concern in performing OPCAB even today. 
Though we have been able to master the technique of positioning the heart by the use of 
various technique and devices, this still remains a major concern. Exposure of the coronary 
artery target sites requires the heart to be lifted, rotated, dislocated and displaced producing 
a distortion of cardiac geometry and consequently hemodynamic fluctuations frequently 
occur. As a result, the early reports of OPCAB described single or double grafts limited to 
anterior target sites. The corrective measures for these hemodynamic changes include 
volume loading, trendelenberg positioning, and displacement of the heart into the opened 
right pleura, use of inotropes, vasopressors, vasodilators, intra-aortic balloon pump, and 
right heart circulatory support [Mathison M.et al, 2000 &, Kim K.B. et al, 2001]. 
What we had re-engineered over the last five years is to avoid the Trendelenberg position. 
And  we practice  an anti-Trendelenberg position of the patient, where the patient lies on 
the table with the head end up. This is very useful in patients with ischemia, where the 
pulmonary artery (PA) pressure is high. This maneuver reduces the PA pressure, and there 
by reduces the left ventricular end diastolic pressure (LVEDP). This is exactly what the 
patient would do when he develops chest pain in his room. He sits up and tries to catch his 
breath. That is what we help him do in the operation theater as he is anaesthetised. 
If the CVP is low and the right ventricle looks empty, then we give a fluid challenge to 
improve his preload. But we always try to avoid the Trendelenberg position.  
In late nineties, the principle of OPCAB was to perform the coronary anastomosis at a heart 
rate of less than 60 per minute. Hence, the patients coming for surgery used to be well beta 
blocked, so that it would be easy to perform the anastomosis. But, most of these patients  
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Fig. 1. Photo showing the operation table with the head end elevated and tilted to the side of 
the surgeon. 
ended up having inotropes and vasoconstrictors to maintain hemodynamics. Ischemic 
patients when given either of them, they develop further ischemia and become bad. 
What we had re-engineered here, was to increase the heart rate .To attain that, we use 
intermittent boluses of Injection Atropine (0.6mgs per milliliter), which is only a 
Chronotropic agent and not an Inotrope. Thus, avoiding unnecessary strain on the 
myocardium. We aim at a rate above 100 per minute and this keeps the heart briskly 
contracting and avoiding the usual hemodynamic collapse seen in the early days. 
We do not use vasopressors or vasodilators in any of our patients undergoing OPCAB.The 
only drug the patient would be given intermittently is the Atropine injection. We use 
Glycerol trinitrate(GTN) in our patients after the distal anastomosis, and that too as an 
antihypertensive only. 
Mueller et al. found no change in the hemodynamics during exposure of the posterior and 
anterior wall arteries, and only marginal change for the lateral wall artery with a ‘no 
compression’ technique [Mueller X.M  et al,2002]. It has been suggested that the use of left 
ventricular apical suction device for cardiac positioning provokes less hemodynamic 
instability compared with pericardial retraction sutures [Sepic J.et al,2002].  
The technique which we have developed is to cut down the pericardium on the right side, down 
to the inferior vena cava, and to leave the right pleura opened. We routinely open the left pleura 
to help in the mammary dissection. Hence, in all our patients we have all the three chambers- the 
mediastinum and both the pleural cavity, remaining in continuity with  each other.  
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Fig. 2. Showing the Positioner verticalising the heart and the stabilizer used on the marginal 
circumflex. 
We too routinely use the Positioner for lifting the apex of the heart. The suction pressure 
used is not more than 150-200 mm of Hg. The positioner is always used in an off apex 
position, so as to avoid sucking the Left anterior descending (LAD) coronary artery. We use 
this pressure to avoid excessive damage to the apex. We also watch the suction tube, to see if 
any blood is being sucked. In such cases , the positioner is removed and repositioned in a 
different place. In case of grafting of the circumflex and the Posterior descending artery 
(PDA) this heart is only Verticalized and not tilted to the right side. This lifting of the apex, 
increases the left and the right ventricular volume. And in case the PDA, is being grafted, 
then we tilt the head end down, so as to increase the visibility of the PDA. This probably 
would be the only time when the Trendelenberg position is used. By this time the LAD is 
already perfused, and this has relieved the ischemia. If the visibility of the circumflex is bad, 
then the table is dropped down to its maximum and the positioner moved to right a bit. 
With this maneuver, even  the Atrioventricular groove could be visualized. 
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Fig. 3. Showing the heart totally verticalized by the use of the positioner, and the stabilizer 
in position around the PDA. 
4. Quality of distal anastamosis 
Performing vascular anastomoses on small arteries on a beating heart can be a daunting and 
frustrating adventure, and so far, no available method of target vessel stabilization can 
achieve a steady bloodless field comparable to an  arrested heart. This was a major concern 
with OPCAB. The beating heart with a bloody operating field poses a major challenge to 
delicate tissue handling, and casts a shadow of uncertainty about the quality of the distal 
anastomosis. However, with the application of effective target vessel stabilization, and 
efficient visualization systems the early and mid-term patency of OPCAB has been 
encouraging  
The stabilizers we use are the suction stabilizers. The position of the stabilizer is very. 
important to achieve a very stable anastomotic site to perform a good coronary anastomosis. 
We have tried all types of suction stabilizers, from the Medtronic -Octopus II, III and the 
Octopus IV. We are now using the Maquet, which was the previous Guidant – Acrobat  
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Fig. 4. Photograph showing the positioner on the RV free wall to graft the distal RCA or the 
acute marginal. 
stabilizer. The Re- engineering in this is the pressure used for suction of these stabilizers. We 
use 100-150 mm of Hg on these stabilizers. The stabilizer is positioned according to the 
convenience of the surgeon. The position of our stabilizer is shown in the photographs. We 
do not use any suction while stabilizing the lateral wall, as the heart is allowed to fall on the 
stabilizer pods. 
In order to achieve a stable bloodless field while accessing the coronary artery, we use the 
following technique. After stabilizing the coronary artery by using the acrobat stabilizer, we 
use a 5.0 polypropelene suture to run around the proximal part of the coronary artery, 
proximal to where the arteriotomy is planned to be made. The two ends of the 5.0 
polypropylene are suspended using rubber shod . They are tightened just before the 
coronary arteriotomy is made. This is made using the bevel of a 18 gauge needle on a 2 ml 
syringe. After the nick is made on the coronary artery, the forward or the backward cutting 
scissors is used to open the coronary artery. A Castroveijo scissors is used to open the 
arteriotomy. The arteriotomy is usually one centimeter long. Then the intra-coronary shunt 
is inserted according to the size of the coronary artery. The shunt is to be deaired after 
inserting the proximal end first, then the snare is released and the then the distal end is 
inserted. Then the anastomosis of the coronary is performed using the conduits as preferred. 
We use shunts in nearly all the distal anastomosis. 
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Fig. 5. Showing the clarity of the coronary anastamosis, while performing LIMA to LAD 
anastamosis. 
5. Incomplete myocardial revascularisation 
Early reports of OPCAB in the literature were uniformly consistent in the low number of 
grafts per patient [6,10]. The selection of patients with mainly single-vessel disease may, in 
part, explain this finding. But the persistence of lower average number of grafts in later 
comparative studies [Gundry S.R et al,1998 &Arom K.V.et al,2000] places OPCAB in a 
contentious position which detracts from its potential benefits. In their retrospective study, 
Gundry and colleagues reported a significantly lower mean number of grafts, and a two-
fold increase in cardiac re-intervention rate during a 7-year period with off-pump 
performed without cardiac stabilization, compared to on-pump CABG. This finding has 
been corroborated by other reports , and exemplifies incomplete revascularization with 
OPCAB. Effective cardiac retraction, stabilization and visualization systems with patient 
positioning enables grafting of all graftable targets, making complete myocardial 
revascularization (CMR) attainable in OPCAB [Calafiore A.M et al 1995 & Cartier R et al, 
2000], and this has been demonstrated in a recent prospective randomized study [Puskas J.D 
et al,2003]. However, incomplete myocardial revascularization with OPCAB is still reported 
in retrospective studies . Technical difficulties due to small caliber of target vessels or their 
intramyocardial course, poor exposure of target sites, precarious intraoperative 
hemodynamic state, electrophysiological instability and inexperience of the surgeon are 
some of the reasons for incomplete myocardial revascularization.  
Today we have no contraindications for OPCAB , the intramyocardial coronary arteries, 
small coronary arteries and diffuse coronary arteries [Anil D Prabhu et al, 2007&2008], have  
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Fig. 6. Showing the dissection on the buried intramuscular coronary artery on the lateral 
wall of the heart. 
been a thing of the past. Any patient who needs to undergo CABG would be able to have his 
coronary artery bypass surgery using the OPCAB technique. 
6. High risk surgical patients 
OPCAB has been demonstrated to offer prognostic advantage over on-pump CABG in 
patients with exaggerated surgical risk from complicated coronary artery disease and/or 
debilitating co-morbidities [Tashiro T et al,1996,Akiyama K.et al,1999,Yokoyama T. et 
al,2000 & Prifti E et al,2000]. More importantly, the preoperative optimization of high risk 
patients plays a crucial role in determining the clinical outcome for both methods of 
myocardial revascularization. 
Acute myocardial infarction and depressed left ventricular function constitute a high 
surgical risk with on-pump CABG, because the myocardial damaging effects of CPB and the 
often cumbersome and, inefficient intraoperative myocardial protection do not prevent 
immediate postoperative cardiac dysfunction [Buckberg Get al,1996,Christenson J.T..et 
al,1997 &.D'Ancona G,2001]. OPCAB achieves comparatively better outcomes in patients 
who have myocardial revascularization soon after recent AMI [Locker C,2001]. Mohr et al. 
[Mohr R et al 1999] reported a mortality of 1.7% with 1- and 5-year actuarial survival rates of 
94.7 and 82.3%, respectively, in a series of 57 patients in which 56% had emergency surgery  
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Fig. 7. Showing the vein graft  after anastomosis on the coronary artery. 
within 48 hr of acute myocardial infarction and some were in cardiogenic shock. OPCAB 
decreases the operative risk in the presence of impaired left ventricular function [Nakayama 
Y.et al,2003] 
Preoperative renal impairment is an independent predictor of poor prognosis after on-pump 
CABG [Ascione R et al 1999]]. OPCAB preserves renal function better than on-pump CABG 
[Ascione R.et al,2001], and available evidence favors the preferential use of OPCAB for 
patients with chronic renal for a better early clinical outcome.  
Patients with coexisting chronic obstructive airway disease derive better early clinical 
benefit from CABG performed without CPB compared with on-pump surgery [Güler M et 
al,2001], although in low-risk patients, OPCAB induces impairment of the mechanics of the 
respiratory system, lung and chest wall similar to on-pump CABG [Roosens C et al,2002].  
Elderly patients are considered high risk surgical patients because of their reduced 
functional capacity and the presence of co-morbidities. Correspondingly, the outcome of on-
pump CABG in this group is characterized by increased morbidity and mortality [Montague 
N.T et al,,1985,,Mullany C.J et al,1980 & Hirose H,2000]. Interestingly, OPCAB has been 
shown to improve the clinical outcome in this growing population of surgical patients [Boyd 
W.D et al, 1999, Stamou S.C et al, 2000, Al-Ruzzeh S et al, 2001 & Hoff S.J.et al, 2002]. 
Specifically, the incidence of stroke, perioperative myocardial infarction, duration of 
mechanical ventilation, blood transfusion, length of intensive care and hospital stay, and 
mortality are decreased.  
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7. Vettath's anastamotic obturator 
In patients with diffusely diseased coronary arteries and in patients with diseased aortas, 
OPCAB has remained a life saver. We had developed the Vettaths anastomotic  obturator 
(VAO) (Murali.P.Vettath,2003,2004) – which , is is an aortic anastomosis enabling  device. 
This allows the surgeon to avoid the side clamp on the aorta, when a no touch technique is 
required in cases of diseased aorta. In patients with plaquey aortas, where a saphenous vein 
top end is to be connected, this could be used to make an anastomosis on a no plaquey zone 
in the aorta. The technique is to identify a soft spot and make two purse string sutures with 
3.0 polypropylene around the intended zone of anastomosis. The purse strings are about a 
centimeter in diameter. A stab wound is made using a no.11 blade and an aortic punch is 
used to make a punch hole on the aorta. The VAO is then inserted into the hole and one of 
the 3.0 purse strings are used to snare the bleeding around the VAO if it persists. The aortic 
systolic pressure may be maintained at around 100 mm of Hg. The advantage is that this 
allows the surgeon to perform a hand sewn anastomosis on the vein graft. This is like the 
devices that are available in the market, like the Heartstring and the Enclose device. This is 
like an instrument and is made of steel and can be reused and could help in avoiding a 
stroke in elderly patients. We have performed more than 500 top ends using this device and 
is a good one to have in the armamentarium of a cardiac surgeon. This is also a good tool to 
use in redo CABG, when a proximal anastomosis could be made on the hood of the old vein 
graft. 
The VAO is also a useful tool in cases where a combined aortic valve replacement is done 
with a CABG. Here it is useful when the side clamp needs to be avoided.  
8. Diffusely diseased coronary arteries 
The diffusely diseased coronary arteries have been a curse in the south East-Asian 
population, and more so in patients with Indian origin. This is seen in these patients in the 
younger age group and they are usually termed inoperable. The disease is so diffuse that 
grafting area in the coronary arteries are studded with plaques. We had developed our own 
technique of Vettath's technique of long mammary patch on LAD without endarterectomy 
on beating heart. We had performed this on more than 200 patients since the last 9 years. We 
have also published the same (Murali Vettath,2008 ) in couple of journals. In fact we have 
been reviewing these patients with coronary angiograms and the results have been quite 
gratifying. 
9. Vettath's technique of long mammary patch 
A single stabilizer is used if the arteriotomy is <4 cm. If it exceeds >4 cm, two stabilizers 
(one facing each other)  are used for coronary stabilization. The arteriotomy extends distally 
to reach the normal lumen of LAD. Proximal extent of arteriotomy is kept just short of the 
most severe proximal lesion to avoid competitive flow from native LAD. 
Distal coronary perfusion during anastomosis is maintained using conventional 
intracoronary shunts (Clearview, Medtronic Inc, Minneapolis, MN, USA). If the arteriotomy 
exceeds 3-4 cm, cut ends of aorto- coronary shunts (Quickflow, Medtronic Inc, Minneapolis, 
MN, USA) are used. These may be tailored to use in arteriotomies upto 6-7 cms. In this 
technique, hither to undescribed (Vettath’s modification of aorto-coronary shunts), the distal 
perfusion tips of aorto- coronary shunts are cut and inserted into the coronary artery. The  
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Fig. 8. Shows the Vettath's anastomotic obturator , the whole length of the device and the 
working end of the piece that goes into the aorta. 
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Fig. 9. Shows the close up of the top end anastomosis in progress using the VAO 
bulb is inserted into the end from where the blood flows (i.e., into distal coronary lumen if 
the flow is retrograde and vice-verse). If the shunt does not sit inside the coronary (or it 
bowstrings), it is tacked down with a tacking suture taken in the midpoint of arteriotomy. 
This tacking suture is taken out at the end of anastomosis, along with the shunt. We use 7-0 
polypropylene for this tacking suture. Occasionally, when native coronary flow is negligible 
and/or coronary lumen is <1 mm, the LAD is snared proximally with circumferential suture 
and LIMA to LAD anastomose was done. LIMA is slit to match the coronary arteriotomy 
and LIMA to LAD anastomosis is performed using 7-0 polypropylene. The plaques are 
excluded from the lumen of the reconstructed LAD. Diagonals and perforators are included 
in the new lumen. Posterior 25% of reconstructed coronary artery is formed by native 
coronary artery and anterior 75% by LIMA . Approximately 10 minutes were taken to 
construct a 2cm patch and an additional 5 minute per each added centimeter of patch was 
taken for anastomosis. 
The advantage of this technique is that the intima is left intact and no injury is made on it. 
The avoidance of endarterectomy is a definite reason for the patency in our study. We also 
do not add any anticoagulants or anything other medications, than those used for the 
normal CABG patients. Also that in spite of our long anastomosis, patients remain quite 
stable all along the anastomotic time.This technique of long patch has also been described by 
Takanashi [S.Takanashi,2003.] 
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Fig. 10. Shows: 
(a) The VAO is inserted into the vein hood of the blocked vein graft. In a re do CABG- On pump. 
(b) The suturing being done on the top end of the vein graft. 
(c) The anastomosed vein graft s in position. 
(d) The top end of the vein graft in a CABG plus AVR done without using side clamp 
10. Role of IABP in OPCAB 
The use of intra-aortic balloon pump (IABP) either preoperatively or intraoperatively, to 
reduce operative risk and to facilitate posterior vessel OPCAB has been well documented. 
IABP has been useful in high-risk patients with left main coronary artery disease (> 75% 
stenosis), intractable resting angina, post infarction angina, left ventricular dysfunction 
(ejection fraction < 35%), or unstable angina.  
Preoperative IABP counterpulsation has been shown to have better outcomes compared 
with perioperative or postoperative insertion in critical patients, and off-pump surgical 
procedures have been advocated to reduce mortality in high-risk patients. 
In patients with high risk factors, higher mortality and morbidity rates have been 
demonstrated in spite of massive pharmacologic support combined with postoperative 
IABP support. IABP therapy results in a more favorable myocardial blood supply, increased 
stroke volume and cardiac output through augmentation of the diastolic pressure, and 
afterload reduction (Christenson, 1997, 1999).Intraoperative or postoperative IABP insertion 
has been reported to be associated with higher operative mortality rate and device-related 
complication rate, as compared with preoperative use of IABP.  
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Fig. 11. Shows the Coronary angiograms of patients, showing diffusely diseased coronary 
arteries. 
 
Fig. 12. Showing the Double stabilizer technique while performing the long mammary patch 
anastomosis of LIMA on the LAD without enadarterectomy. 
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Any patient who has a hemodynamic compromise or has an inclination to crash, gets an 
IABP inserted sheath less.(8 or &7 Fr). We had the IABP inserted in the early days when we 
had the patient included in one of the high risk group like- left main coronary artery disease 
(> 75% stenosis), intractable resting angina, ST depression more than 2.5mm,Post-infarction 
angina, Left ventricular dysfunction (ejection fraction < 35%), or unstable angina. 
We had noticed that the use of IABP was not high in the left main disease group and low 
ejection fraction group, but was high in patients with ongoing ischemia. Hence we re-
engineered our use of IABP such that every patient undergoing OPCAB gets a femoral 
arterial line and this is used for monitoring along with the radial arterial line. When a 
patient becomes ischemic during lifting the heart and while positioning for lateral wall 
grafting, then the heart is repositioned, and a sheathless IABP inserted. This is then used till 
the distal anastomosis is over. Once the anastomosis is complete and the heart repositioned 
for top end anastomosis, then the IABP is kept on standby mode. Then after the top end 
anastomosis is over, the heparin is reversed. Once the reversal is over and when the patient 
remains hemodynamically stable, we remove the IABP on the table, after inserting another 
femoral arterial line in the other groin. This technique has been very useful and we have 
been following this for the past four years, with excellent results. In fact this technique is 
being sent for publication. We have not had to reintroduce any IABP in any of these patients 
over the last four years. 
 
 
11. Results 
We had analyzed the results of our last 2000 OPCAB patients. It was noticed that we had a 
higher rate of conversion onto the heart lung machine in our first thousand, when compared 
the second thousand. Probably, that was our initial learning curve which was seen in our 
technique, which we have developed and standardized. The use of IABP had been low in the 
early years, and probably the reason for the increased conversion on to the Heart lung 
machine. But as we understood the use of IABP, we found it more user friendly. Also the need 
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for the balloon pump only for distal anastomosis did come as a surprise to us. In the last 1600 
odd patients, we had to convert only one patient on to the heart lung patient (That too when 
the patient developed intractable Ventricular arrhythmia). The mortality of the second 
thousand patients had come down by half and we have been able to maintain that result. 
Our results of the different parameters like the use of ionotropes, number of grafts, Renal 
failure, perioperative Myocardial infarction etc, in comparison with our two groups of 
patients have been elucidated in the Table below. 
 
 
12. Conclusion 
The advance that has been made in the surgical management of coronary artery disease has 
placed us in a vantage position of judging the outcome of our management techniques not 
only by morbidity and mortality incurred, but also by the potential of our treatment 
modality to cause harm. This is why OPCAB has generated renewed, widespread and 
sustained interest. The resurgence of OPCAB has also ignited a keen enthusiasm in the 
refinement of CPB techniques and the management of on-pump CABG patients. In most 
practices, OPCAB is paradoxically dependent on, and guaranteed by the presence of the 
CPB machine. We would like to stress here that OPCAB is not for everyone. It is definitely 
not for the faint hearted surgeon, It needs a Team with a MINDSET. And the team has to 
gear itself from being able to perform CABG on full Cardiopulmonary bypass, with cross 
clamp and cardoplegia, to performing CABG on pump with a beating heart, and then going 
on to just cannulating the aorta, and then stabilizing the heart and performing OPCAB, to 
doing a full OPCAB. This should be a slow transition, than a sudden change. Then the 
results would be good. There has been numerous article comparing OPCAB with ONCAB, 
but in our opinion, a surgeon performing OPCAB would not have to perform ONCAB, what 
ever the coronary anatomy is, if he sets his mind to it. 
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In our last 12 years of OPCAB experience and over 2500 OPCABs, we have been able to 
perform the last 1600 OPCABs with only one conversion to the heart lung machine. That 
was when patient developed intractable arrhythmia. Hence in our opinion, intractable 
arrhythmia is the only reason for conversion. The mortality in the first one thousand 
patients have been 0.8% and in the second thousand is 0.4%.This proves to say that OPCAB 
has definitely reduced the mortality in coronary surgery. And if trained well we would be 
able to perform the same in patients with any ejection fraction. 
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